FTLF vs HIMS vs TDOC vs SMPL vs AMWL

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -2. 0% for American Well Corporation (AMWL). FitLife Brands, Inc. (FTLF) offers the better valuation at 10. 5x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate FitLife Brands, Inc. (FTLF) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, FitLife Brands, Inc.

(FTLF) is the cheapest at 10. 5x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, FitLife Brands, Inc. is actually cheaper at 7. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: FitLife Brands, Inc. wins at 0. 27x versus The Simply Good Foods Company's 0. 31x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -97. 2% for American Well Corporation (AMWL). Over 10 years, the gap is even starker: FTLF returned +175. 5% versus AMWL's -98. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), FitLife Brands, Inc.

(FTLF) is the lower-risk stock at 0. 34β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 607% more volatile than FTLF relative to the S&P 500. On balance sheet safety, American Well Corporation (AMWL) carries a lower debt/equity ratio of 2% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -2. 0% for American Well Corporation (AMWL). On earnings-per-share growth, the picture is similar: Teladoc Health, Inc. grew EPS 80. 6% year-over-year, compared to -26. 1% for The Simply Good Foods Company. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

FitLife Brands, Inc.

(FTLF) is the more profitable company, earning 13. 9% net margin versus -38. 4% for American Well Corporation — meaning it keeps 13. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FTLF leads at 20. 3% versus -42. 2% for AMWL. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, FitLife Brands, Inc. (FTLF) is the more undervalued stock at a PEG of 0. 27x versus The Simply Good Foods Company's 0. 31x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, FitLife Brands, Inc. (FTLF) trades at 7. 0x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 44. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FTLF: 219. 0% to $30. 50.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, FitLife Brands, Inc.

(FTLF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 34), +175. 5% 10Y return). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FTLF: +175. 5%, TDOC: -41. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (FTLF (Consumer Defensive) and HIMS (Healthcare) and TDOC (Healthcare) and SMPL (Consumer Defensive) and AMWL (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FTLF is a small-cap high-growth stock; HIMS is a small-cap high-growth stock; TDOC is a small-cap quality compounder stock; SMPL is a small-cap deep-value stock; AMWL is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.